Search

Your search keyword '"Zaratin, P"' showing total 240 results
Start Over Author "Zaratin, P"
240 results on '"Zaratin, P"'

2. Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study

Author

Masciulli, Camilla, Portaccio, E., Goretti, B., Niccolai, C., Simone, M., Viterbo, R. G., Zaffaroni, M., Pippolo, L., Cocco, E., Fenu, G., Carta, E., Falautano, M., Celico, C., Pardini, M., Mancardi, G. L., Guerrini, R., Melani, F., Giovannelli, F., Rocca, M., Iaffaldano, P., Tacchino, A., Zaratin, P., Filippi, M., and Amato, M. P.

Published
2025
Full Text
View/download PDF

6. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Author

Sormani, Maria P, De Rossi, Nicola, Schiavetti, Irene, Carmisciano, Luca, Cordioli, Cinzia, Moiola, Lucia, Radaelli, Marta, Immovilli, Paolo, Capobianco, Marco, Trojano, Maria, Zaratin, Paola, Tedeschi, Gioacchino, Comi, Giancarlo, Battaglia, Mario A, Patti, Francesco, Salvetti, Marco, Nozzolillo, Agostino, Bellacosa, Alessandra, Protti, Alessandra, Di Sapio, Alessia, Signori, Alessio, Petrone, Alfredo, Bisecco, Alvino, Iovino, Aniello, Dutto, Anna, Repice, Anna Maria, Conte, Antonella, Bertolotto, Antonio, Bosco, Antonio, Gallo, Antonio, Zito, Antonio, Sartori, Arianna, Giometto, Bruno, Tortorella, Carla, Antozzi, Carlo, Pozzilli, Carlo, Mancinelli, Chiara Rosa, Zanetta, Chiara, Cordano, Christian, Scandellari, Cinzia, Guaschino, Clara, Gasperini, Claudio, Solaro, Claudio, Fioretti, Cristina, Bezzini, Daiana, Marastoni, Damiano, Paolicelli, Damiano, Vecchio, Domizia, Landi, Doriana, Bucciantini, Elisabetta, Pedrazzoli, Elisabetta, Signoriello, Elisabetta, Sbragia, Elvira, Susani, Emanuela Laura, Curti, Erica, Milano, Eva, Marinelli, Fabiana, Camilli, Federico, Boneschi, Filippo Martinelli, Govone, Flora, Bovis, Francesca, Calabria, Francesca, Caleri, Francesca, Rinaldi, Francesca, Vitetta, Francesca, Corea, Francesco, Crescenzo, Francesco, Teatini, Francesco, Tabiadon, Giulietta, Granella, Franco, Boffa, Giacomo, Lus, Giacomo, Brichetto, Giampaolo, Maniscalco, Giorgia Teresa, Borriello, Giovanna, De Luca, Giovanna, Konrad, Giovanna, Vaula, Giovanna, Marfia, Girolama Alessandra, Mallucci, Giulia, Liberatore, Giuseppe, Salemi, Giuseppe, Miele, Giuseppina, Sibilia, Grazia, Pesci, Ilaria, Brambilla, Laura, Lopiano, Leonardo, Sinisi, Leonardo, Pasquali, Livia, Saraceno, Lorenzo, Chiveri, Luca, Mancinelli, Luca, and Grimaldi, Luigi ME

Subjects
Pneumonia & Influenza, Neurodegenerative, Clinical Research, Autoimmune Disease, Brain Disorders, Lung, Multiple Sclerosis, Pneumonia, Neurosciences, Neurological, Good Health and Well Being, Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, COVID-19, Dimethyl Fumarate, Female, Fingolimod Hydrochloride, Hospitalization, Humans, Immunologic Factors, Immunosuppressive Agents, Intensive Care Units, Interferons, Male, Middle Aged, Mortality, Natalizumab, SARS-CoV-2, Severity of Illness Index, Young Adult, Musc-19 Study Group, Clinical Sciences, Neurology & Neurosurgery
Abstract

ObjectiveThis study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS).MethodsWe retrospectively collected data of PwMS with suspected or confirmed COVID-19. All the patients had complete follow-up to death or recovery. Severe COVID-19 was defined by a 3-level variable: mild disease not requiring hospitalization versus pneumonia or hospitalization versus intensive care unit (ICU) admission or death. We evaluated baseline characteristics and MS therapies associated with severe COVID-19 by multivariate and propensity score (PS)-weighted ordinal logistic models. Sensitivity analyses were run to confirm the results.ResultsOf 844 PwMS with suspected (n = 565) or confirmed (n = 279) COVID-19, 13 (1.54%) died; 11 of them were in a progressive MS phase, and 8 were without any therapy. Thirty-eight (4.5%) were admitted to an ICU; 99 (11.7%) had radiologically documented pneumonia; 96 (11.4%) were hospitalized. After adjusting for region, age, sex, progressive MS course, Expanded Disability Status Scale, disease duration, body mass index, comorbidities, and recent methylprednisolone use, therapy with an anti-CD20 agent (ocrelizumab or rituximab) was significantly associated (odds ratio [OR] = 2.37, 95% confidence interval [CI] = 1.18-4.74, p = 0.015) with increased risk of severe COVID-19. Recent use (

Published
2021

10. Multiple sclerosis registries in Europe – An updated mapping survey

Author

Glaser, A., Stahmann, A., Meissner, T., Flachenecker, P., Horáková, D., Zaratin, P., Brichetto, G., Pugliatti, M., Rienhoff, O., Vukusic, S., de Giacomoni, A.C., Battaglia, M.A., Brola, W., Butzkueven, H., Casey, R., Drulovic, J., Eichstädt, K., Hellwig, K., Iaffaldano, P., Ioannidou, E., Kuhle, J., Lycke, K., Magyari, M., Malbaša, T., Middleton, R., Myhr, K.M., Notas, K., Orologas, A., Otero-Romero, S., Pekmezovic, T., Sastre-Garriga, J., Seeldrayers, P., Soilu-Hänninen, M., Stawiarz, L., Trojano, M., Ziemssen, T., Hillert, J., and Thalheim, C.

Published
2019
Full Text
View/download PDF

12. The Italian multiple sclerosis register

Author

Trojano, Maria, Bergamaschi, Roberto, Amato, Maria Pia, Comi, Giancarlo, Ghezzi, Angelo, Lepore, Vito, Marrosu, Maria Giovanna, Mosconi, Paola, Patti, Francesco, Ponzio, Michela, Zaratin, Paola, Battaglia, Mario Alberto, and on behalf of the Italian Multiple Sclerosis Register Centers Group

Published
2019
Full Text
View/download PDF

15. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions

Author

Zaratin, P, Vermersch, P, Amato, M, Brichetto, G, Coetzee, T, Cutter, G, Edan, G, Giovannoni, G, Gray, E, Hartung, H, Hobart, J, Helme, A, Hyde, R, Khan, U, Leocani, L, Mantovani, L, Mcburney, R, Montalban, X, Penner, I, Uitdehaag, B, Valentine, P, Weiland, H, Bertorello, D, Battaglia, M, Baneke, P, Comi, G, Zaratin P., Vermersch P., Amato M. P., Brichetto G., Coetzee T., Cutter G., Edan G., Giovannoni G., Gray E., Hartung H. P., Hobart J., Helme A., Hyde R., Khan U., Leocani L., Mantovani L. G., McBurney R., Montalban X., Penner I. -K., Uitdehaag B. M. J., Valentine P., Weiland H., Bertorello D., Battaglia M. A., Baneke P., Comi G., Zaratin, P, Vermersch, P, Amato, M, Brichetto, G, Coetzee, T, Cutter, G, Edan, G, Giovannoni, G, Gray, E, Hartung, H, Hobart, J, Helme, A, Hyde, R, Khan, U, Leocani, L, Mantovani, L, Mcburney, R, Montalban, X, Penner, I, Uitdehaag, B, Valentine, P, Weiland, H, Bertorello, D, Battaglia, M, Baneke, P, Comi, G, Zaratin P., Vermersch P., Amato M. P., Brichetto G., Coetzee T., Cutter G., Edan G., Giovannoni G., Gray E., Hartung H. P., Hobart J., Helme A., Hyde R., Khan U., Leocani L., Mantovani L. G., McBurney R., Montalban X., Penner I. -K., Uitdehaag B. M. J., Valentine P., Weiland H., Bertorello D., Battaglia M. A., Baneke P., and Comi G.

Abstract

On 12 September 2019, the global Patient Reported Outcome for Multiple Sclerosis (PROMS) Initiative was launched at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). The multi-stakeholder PROMS Initiative is jointly led by the European Charcot Foundation (ECF) and the Multiple Sclerosis International Federation (MSIF), with the Italian Multiple Sclerosis Society (AISM) acting as the lead agency for and on behalf of the global MSIF movement. The initiative has the ambitious mission to (i) maximize the impact of science with and of patient input on the life of people affected by MS, and (ii) to represent a unified view on Patient-Reported Outcomes for MS to people affected by MS, healthcare providers, regulatory agencies and Health Technologies Assessments agencies. Equipped with an innovative participatory governance of an international and interdisciplinary network of different stakeholders, PROMS has the potential to guide future breakthroughs in MS patient-focused research and care. In this paper we present the progresses of the global PROMS Initiative and discuss the open questions that we aim to address.

Published
2022

16. Defoliation and nitrogen fertilization on the physiological quality of soybean seeds.

Author

Cabrera Baptista de Aguiar, Viviane, Alves Fernandes, Marcio, Zuffo, Alan Mario, Ratke, Rafael Felippe, González Aguilera, Jorge, Benetoli da Silva, Tiago Roque, and Zaratin Alves, Charline

Abstract

Stress caused by defoliation can compromise the physiological quality of soybean seeds. However, there is evidence that the application of nitrogen (N) can be an alternative to reduce the qualitative losses in seeds caused by defoliating insects. The objective of this study was to evaluate the effectiveness of topdressing N fertilization in improving the physiological quality of soybean seeds from plants subjected to artificial defoliation. The experimental design was a randomized block arranged in a 2x4 factorial scheme with four replicates. The treatments consisted of two levels of defoliation (33 and 66%) and four doses of N (0, 50, 100, and 150 kg ha-1), using urea (45% N), applied two days after defoliation. Artificial defoliation was performed during the R3 stage by removing one (33%) and two leaflets (66%) from each trifoliate leaf under field conditions. At stage R5.1, leaf area was quantified, and after harvesting, germination, emergence, length, total dry mass, electrical conductivity, total protein content, mass of 1000 seeds, and tetrazolium (vigor and viability) tests were carried out. It was concluded that increasing the defoliation from 33 to 66% impaired the physiological quality of soybean seeds. The use of nitrogen fertilization for coverage after defoliation at the beginning of the reproductive phase cannot minimize qualitative losses in seeds. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Impact of harvest delay on the physiological and sanitary quality of Sorghum sp. seeds.

Author

Guimarães Martins, Antonio, Zuffo, Alan Mario, Matos Barrozo, Leandra, Mezzomo, Ricardo, dos Santo Silva, Francisco Charles S., Steiner, Fabio, Andrade dos Santos, Raianara, and Zaratin Alves, Charline

Abstract

Harvest delay can alter the physiological and sanitary quality of sorghum seeds due to the longer exposure time of seeds to adverse environmental conditions in the field. In this study, we investigated the impact of delayed Sorghum sp. harvest on the physiological and sanitary quality of seeds in four hybrids grown in the tropical soil of the Brazilian Cerrado region. Plants from four Sorghum sp. hybrids (IPA SUDAN 4202, BRS 658, BRS 810, and BRS 373) were grown and submitted to four seed harvest periods (0, 7, 14, and 21 days after stage 9 -- seed physiological maturity). The treatments were arranged in a completely randomized block design in a 4 x 4 factorial, with four replicates. At each harvest period, the t housand-seed weight, water content, first count of the germination test, germination, seedling emergence, emergence speed index, seedling dry matter, accelerated aging, electrical conductivity, and sanitary quality of seeds were determined. Seeds of higher physiological and sanitary quality of the IPA SUDAN 4202 and BRS 658 sorghum hybrids can be obtained when the harvest is carried out up to 7 days after the physiological maturity stage. However, the delay in seed harvesting at 14 and 21 days after physiological maturity results in a higher incidence of Colletotrichum sp., Curvularia sp., Rhizoctonia sp., and Alternaria sp. on the seeds of these hybrids. Delaying the harvest of sorghum seeds from 7 days after the physiological maturity stage compromises seed vigor and viability and increases the incidence of pathogens. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

18. X-rays for determination of papaya seeds viability.

Author

Alves Nogueira, Graziely, Fernandes Xavier, Gabriela, Roque Benetoli Silva, Tiago, Bacchetta, Gianluigi, Barros Torres, Salvador, Dias Pereira, Marcio, Dutra, Alek Sandro, and Zaratin Alves, Charline

Abstract

This study investigated the effectiveness of using the X-ray technique to assess the viability of papaya seeds. The X-ray images were performed in eight replicates of 25 seeds, placed on transparent acrylic plates on double-sided adhesive tape, previously identified, and then submitted to radiation in X-ray equipment "HP Faxitron". After exposure to X-ray radiation, the seeds were submitted to the germination test in rolls of germitest paper and kept in a germination chamber at 20-30 °C for 30 days. Seedlings were photographed and evaluated as normal seedlings, abnormal and non-germinated seeds. Afterward, the X-ray images and the seedlings from the same seeds were visually compared, and the X-ray images clearly showed seeds with and without internal filling. All abnormal seedlings were full seeds; therefore, X-ray images were not able to separate normal and abnormal. A 100% accuracy was verified by comparing the X-ray images and their respective seedlings, full seeds originated normal or abnormal seedlings, and empty seeds corresponded to non-germinated seeds. Therefore, using X-ray images is a promising technique to identify the viability of papaya seeds. The automated analysis of X-ray images is a simple, fast, and efficient technique to provide information on seed viability and generate parameters related to their germination capacity. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Correction to: The Italian multiple sclerosis register

Author

Trojano, Maria, Bergamaschi, Roberto, Amato, Maria Pia, Comi, Giancarlo, Ghezzi, Angelo, Lepore, Vito, Marrosu, Maria Giovanna, Mosconi, Paola, Patti, Francesco, Ponzio, Michela, Zaratin, Paola, Battaglia, Mario Alberto, and Italian Multiple Sclerosis Register Centers Group

Published
2019
Full Text
View/download PDF

28. Viability of melon seeds using the pH testing of exudate.

Author

Dantas de Oliveira Costa, Jéssica Christie, Pereira Benedito, Clarisse, Oliveira Pereira, Kleane Targino, Barros Torres, Salvador, Zildo da Silva, Givanildo, and Zaratin Alves, Charline

Abstract

Copyright of Journal of Seed Science is the property of Associacao Brasileira de Tecnologia de Sementes and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2023
Full Text
View/download PDF

29. Morphophysiological and biochemical changes in Enterolobium contortisiliquum seedlings under abiotic stresses.

Author

dos Santos Ferreira, Adriana, Pereira Leal, Caio César, de Sousa Leite, Moadir, Pereira Benedito, Clarisse, Sandro Dutra, Alek, Zaratin Alves, Charline, Costa de Morais, Elis Regina, Dias Pereira, Márcio, Porceddu, Marco, Bacchetta, Gianluigi, and Barros Torres, Salvador

Abstract

Among the main problems that compromise the development of forest species are water and salt stresses, especially in the early stages of development, when seedlings are more sensitive. Thus, the objective of this study was to evaluate the morphophysiological and biochemical changes in Enterolobium contortisiliquum seedlings subjected to abiotic stresses. The experimental design was randomized complete blocks (RCB), composed of five treatments, with four replicates, and the experimental plot consisted of twenty plants. From the 31st day after sowing, when the seedlings reached approximately 15 cm in height, they began to receive the treatments, which consisted of different levels of electrical conductivity of irrigation water (0.3; 2; 4; 6; 8 dS m-1) for salt stress and periods of water restriction (0; 4; 8; 12 and 16 days without irrigation) for water stress. The traits evaluated were: plant height, root length, stem diameter, number of leaves, leaf area, total dry matter, Dickson quality index, height/shoot dry matter ratio, total soluble sugars, starch, total amino acids and proline. An increase in the electrical conductivity of irrigation water and days without irrigation compromised the development of E. contortisiliquum seedlings, which was intensified from 2 dS m-1 and four days without irrigation for salt and water stresses, respectively. The mechanism of survival of E. contortisiliquum to abiotic stresses involves reduction in the growth and quality of seedlings, with activation of biochemical defense mechanisms of the species. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

30. Primary root emission as a vigor test in soybean seeds.

Author

Queiroz Rego, Carlos Henrique, Leite de Brito, Douglas, Barros Torres, Salvador, Costa de Morais, Elis Regina, Dias Pereira, Marcio, Sandro Dutra, Alek, Bacchetta, Gianluigi, and Alves, Charline Zaratin

Abstract

The objective was to verify if the primary root emission can be recommended as a vigor test for soybean seeds. For this, five lots of varieties ANTA 82, NA7337 and BRS1074IPRO were evaluated by first count, germination, emergence, emergence speed index and tetrazolium tests. In the root protrusion test at 20, 25 and 30 °C, two evaluation criteria were adopted: primary root emission precocity index (PREPI) and percentage of seeds that emitted the primary root (PRE). The seeds counted were those with a primary root equal to or greater than 2 mm, every 12 h from the installation of the test until 120 h. The design was completely randomized and means were compared, within each evaluation time, using the Scott-Knott test at 5% probability. Pearson's linear correlation was performed for PREPI and PRE with emergence. PREPI was not considered efficient. For the PRE, at 20 °C, there was a correlation at 72 h, for the three varieties. At 25 °C there was a correlation for a period of 36 h for ANTA 82 and NA7337 and 60 h for BRS1074IPRO. At 30 °C there was a correlation in the time of 36 h for the three cultivars. Considering that speed in obtaining results is important in vigor tests, it is concluded that primary root emission for 36 h after installing the test at 30 °C is recommended as a vigor test in the quality control of soybean seeds. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

31. The Italian multiple sclerosis register

Author

Trojano, M, Bergamaschi, R, Amato, Mp, Comi, G, Ghezzi, A, Lepore, V, 7, Marrosu, Mg, Mosconi, P, Patti, F, Ponzio, M, Zaratin, P, Battaglia, Ma1, Acquistapace D, Italian Multiple Sclerosis Register Centers Group., Aguglia, U, Annunziata, P, Ardito, B, Avolio, C, Balgera, R, Bandini, F, Banfi, P, Barone, P, Bellantonio, P, Bertolotto, A, Bertora, P, Bombardi, R, Bosco Zimatore, G, Bossio, Rb, Bramanti, P, Brescia Morra, V, Brioschi, Am, Bruzzone, M, Buccafusca, M, Busillo, V, Caneve, G, Caniatti, Lm, Capone, L, Capone, F, Cappellani, A, Cargnelutti, D, Cavaletti, G, Cavalla, P, Celani, Mg, Centonze, D, Chiveri, L, Clerici, R, Clerico, M, Cocco, E, Comi, C, Coniglio, Mg, Cordera, S, Corea, F, Cortese, A, Costantino, G, Cottone, S, Crociani, P, D'Andrea, F, Danni, Mc, De Luca, G, de Pascalis, D, De Robertis, F, De Stefano, N, Di Battista, G, Di Napoli, M, Falcini, M, Fausto, F, Ferrò, Mt, Florio, C, Fortunato, M, Frittelli, C, Galgani, S, Gallo, P, Gatto, M, Gazzola, P, Geda, C, Giordano, A, Granella, F, Grasso, Mg, Grimaldi, Lme, Imperiale, D, Lo Russo, L, Logullo, Fo, Lugaresi, A, Lus, G, Maccarrone, G, Maimone, D, Malagù, S, Marconi, R, Maritato, P, Massacesi, L, Mazzoni, M, Meucci, G, Mirabella, M, Montepietra, S, Nasuelli, D, Neri, W, Orefice, G, Parodi, S, Pasquali, L, Passarella, B, Peresson, M, Perla, F, Pesci, I, Piantadosi, C, Piras, Ml, Pizio, Nr, Pozzilli, C, Protti, A, Pugliatti, M, Quatrale, R, Ragno, M, Rezzonico, M, Ribizzi, G, Riva, M, Ronzoni, M, Rosso, Mg, Rottoli, M, Rovaris, M, Salemi, G, Salvetti, M, Santangelo, M, Santangelo, G, Santuccio, G, Sarchielli, P, Scarpini, E, Sechi, Gp, Severi, S, Sinisi, L, Sola, P, Spitaleri, D, Tassinari, T, Tedeschi, G, Tonietti, S, Torri Clerici, V, Totaro, R, Traccis, S, Turla, M, Uccelli, A, Ulivelli, M, Valentino, P, Valeriani, M, Venturi, S, Vianello, M, Zaffaroni, M., Trojano M., Bergamaschi R., Amato M.P., Comi G., Ghezzi A., Lepore V., Marrosu M.G., Mosconi P., Patti F., Ponzio M., Zaratin P., Battaglia M.A., Acquistapace D., Aguglia U., Annunziata P., Ardito B., Avolio C., Balgera R., Bandini F., Banfi P., Barone P., Bellantonio P., Bertolotto A., Bertora P., Bombardi R., Bosco Zimatore G., Bossio R.B., Bramanti P., Brescia Morra V., Brioschi A.M., Bruzzone M., Buccafusca M., Busillo V., Caneve G., Caniatti L.M., Capone L., Capone F., Cappellani A., Cargnelutti D., Cavaletti G., Cavalla P., Celani M.G., Centonze D., Chiveri L., Clerici R., Clerico M., Cocco E., Comi C., Coniglio M.G., Cordera S., Corea F., Cortese A., Costantino G., Cottone S., Crociani P., D'Andrea F., Danni M.C., De Luca G., de Pascalis D., De Robertis F., De Stefano N., Di Battista G., Di Napoli M., Falcini M., Fausto F., Ferro M.T., Florio C., Fortunato M., Frittelli C., Galgani S., Gallo P., Gatto M., Gazzola P., Geda C., Giordano A., Granella F., Grasso M.G., Grimaldi L.M.E., Imperiale D., Lo Russo L., Logullo F.O., Lugaresi A., Lus G., Maccarrone G., Maimone D., Malagu S., Marconi R., Maritato P., Massacesi L., Mazzoni M., Meucci G., Mirabella M., Montepietra S., Nasuelli D., Neri W., Orefice G., Parodi S., Pasquali L., Passarella B., Peresson M., Perla F., Pesci I., Piantadosi C., Piras M.L., Pizio N.R., Pozzilli C., Protti A., Pugliatti M., Quatrale R., Ragno M., Rezzonico M., Ribizzi G., Riva M., Ronzoni M., Rosso M.G., Rottoli M., Rovaris M., Salemi G., Salvetti M., Santangelo M., Santangelo G., Santuccio G., Sarchielli P., Scarpini E., Sechi G.P., Severi S., Sinisi L., Sola P., Spitaleri D., Tassinari T., Tedeschi G., Tonietti S., Torri Clerici V., Totaro R., Traccis S., Turla M., Uccelli A., Ulivelli M., Valentino P., Valeriani M., Venturi S., Vianello M., Zaffaroni M., Trojano M, Bergamaschi R, Amato M.P, Comi G, Ghezzi A, Lepore V, Marrosu M.G, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia M.A, Acquistapace D., Aguglia U., Annunziata P., Ardito B., Avolio C., Balgera R., Bandini F., Banfi P., Barone P., Bellantonio P., Bertolotto A., Bertora P., Bombardi R., Bosco Zimatore G., Bossio R.B., Bramanti P., Brescia Morra V., Brioschi A.M., Bruzzone M., Buccafusca M., Busillo V., Caneve G., Caniatti L.M., Capone L., Capone F., Cappellani A., Cargnelutti D., Cavaletti G., Cavalla P., Celani M.G., Centonze D., Chiveri L., Clerici R., Clerico M., Cocco E., Comi C., Coniglio M.G., Cordera S., Corea F., Cortese A., Costantino G., Cottone S., Crociani P., D’Andrea F., Danni M.C., De Luca G., de Pascalis D., De Robertis F., De Stefano N., Di Battista G., Di Napoli M., Falcini M., Fausto F., Ferrò M.T., Florio C., Fortunato M., Frittelli C., Galgani S., Gallo P., Gatto M., Gazzola P., Geda C., Giordano A., Granella F., Grasso M.G., Grimaldi L.M.E., Imperiale D., Lo Russo L., Logullo F.O., Lugaresi A., Lus G., Maccarrone G., Maimone D., Malagù S., Marconi R., Maritato P., Massacesi L., Mazzoni M., Meucci G., Mirabella M., Montepietra S., Nasuelli D., Neri W., Orefice G., Parodi S., Pasquali L., Passarella B., Peresson M., Perla F., Pesci I., Piantadosi C., Piras M.L., Pizio N.R., Pozzilli C., Protti A., Pugliatti M., Quatrale R., Ragno M., Rezzonico M., Ribizzi G., Riva M., Ronzoni M., Rosso M.G., Rottoli M., Rovaris M., Salemi G., Salvetti M., Santangelo M., Santangelo G., Santuccio G., Sarchielli P., Scarpini E., Sechi G.P., Severi S., Sinisi L., Sola P, Spitaleri D., Tassinari T., Tedeschi G., Tonietti S., Torri Clerici V., Totaro R., Traccis S., Turla M., Uccelli A., Ulivelli M., Valentino P., Valeriani M., Venturi S., Vianello M., Zaffaroni M., Trojano, Maria, Bergamaschi, Roberto, Amato, Maria Pia, Comi, Giancarlo, Ghezzi, Angelo, Lepore, Vito, Marrosu, Maria Giovanna, Mosconi, Paola, Patti, Francesco, Ponzio, Michela, Zaratin, Paola, Battaglia, Mario Alberto, Acquistapace, D, Aguglia, U, Amato, Mp, Annunziata, P, Ardito, B, Avolio, C, Balgera, R, Bandini, F, Banfi, P, Barone, P, Bellantonio, P, Bergamaschi, R, Bertolotto, A, Bertora, P, Bombardi, R, Bosco Zimatore, G, Bossio, Rb, Bramanti, P, Brescia Morra, V, Brioschi, Am, Bruzzone, M, Buccafusca, M, Busillo, V, Caneve, G, Caniatti, Lm, Capone, L, Capone, F, Cappellani, A, Cargnelutti, D, Cavaletti, G, Cavalla, P, Celani, Mg, Centonze, D, Chiveri, L, Clerici, R, Clerico, M, Cocco, E, Comi, G, Comi, C, Coniglio, Mg, Cordera, S, Corea, F, Cortese, A, Costantino, G, Cottone, S, Crociani, P, D'Andrea, F, Danni, Mc, De Luca, G, de Pascalis, D, De Robertis, F, De Stefano, N, Di Battista, G, Di Napoli, M, Falcini, M, Fausto, F, Ferrò, Mt, Florio, C, Fortunato, M, Frittelli, C, Galgani, S, Gallo, P, Gatto, M, Gazzola, P, Geda, C, Giordano, A, Granella, F, Grasso, Mg, Grimaldi, Lme, Imperiale, D, Lo Russo, L, Logullo, Fo, Lugaresi, A, Lus, G, Maccarrone, G, Maimone, D, Malagù, S, Marconi, R, Maritato, P, Massacesi, L, Mazzoni, M, Meucci, G, Mirabella, M, Montepietra, S, Nasuelli, D, Neri, W, Orefice, G, Parodi, S, Pasquali, L, Passarella, B, Patti, F, Peresson, M, Perla, F, Pesci, I, Piantadosi, C, Piras, Ml, Pizio, Nr, Pozzilli, C, Protti, A, Pugliatti, M, Quatrale, R, Ragno, M, Rezzonico, M, Ribizzi, G, Riva, M, Ronzoni, M, Rosso, Mg, Rottoli, M, Rovaris, M, Salemi, G, Salvetti, M, Santangelo, M, Santangelo, G, Santuccio, G, Sarchielli, P, Scarpini, E, Sechi, Gp, Severi, S, Sinisi, L, Sola, P, Spitaleri, D, Tassinari, T, Tedeschi, G, Tonietti, S, Torri Clerici, V, Totaro, R, Traccis, S, Trojano, M, Turla, M, Uccelli, A, Ulivelli, M, Valentino, P, Valeriani, M, Venturi, S, Vianello, M, Zaffaroni, M., Amato, M, Ghezzi, A, Lepore, V, Marrosu, M, Mosconi, P, Ponzio, M, Zaratin, P, Battaglia, M, Bossio, R, Brioschi, A, Caniatti, L, Celani, M, Coniglio, M, D’Andrea, F, Danni, M, Ferrò, M, Grasso, M, Grimaldi, L, Logullo, F, Piras, M, Pizio, N, Rosso, M, Sechi, G, and Zaffaroni, M

Subjects
Register (sociolinguistics), Adult, Male, Knowledge management, Databases, Factual, Epidemiology, media_common.quotation_subject, Disease epidemiology, Multiple sclerosis, Quality of care, Register, Longitudinal Studie, Dermatology, NO, Cohort Studies, Databases, 03 medical and health sciences, 0302 clinical medicine, Multiple Sclerosi, Humans, Quality (business), Longitudinal Studies, 030212 general & internal medicine, Registries, Epidemiology, Multiple sclerosis, Quality of care, Register, Adult, Cohort Studies, Data Collection, Databases, Factual, Female, Humans, Italy, Longitudinal Studies, Male, Multiple Sclerosis, Registries, Factual, media_common, Data collection, business.industry, Data Collection, Correction, Female, Italy, Multiple Sclerosis, General Medicine, Register data, Psychiatry and Mental Health, Observational study, Original Article, Settore MED/26 - Neurologia, Business, Neurology (clinical), Cohort Studie, 030217 neurology & neurosurgery, 2708, Human
Abstract

The past decade has seen extraordinary increase in worldwide availability of and access to several large multiple sclerosis (MS) databases and registries. MS registries represent powerful tools to provide meaningful information on the burden, natural history, and long-term safety and effectiveness of treatments. Moreover, patients, physicians, industry, and policy makers have an active interest in real-world observational studies based on register data, as they have the potential to answer the questions that are most relevant to daily treatment decision-making. In 2014, the Italian MS Foundation, in collaboration with the Italian MS clinical centers, promoted and funded the creation of the Italian MS Register, a project in continuity with the existing Italian MS Database Network set up from 2001. Main objective of the Italian MS Register is to create an organized multicenter structure to collect data of all MS patients for better defining the disease epidemiology, improving quality of care, and promoting research projects in high-priority areas. The aim of this article is to present the current framework and network of the Italian MS register, including the methodology used to improve the quality of data collection and to facilitate the exchange of data and the collaboration among national and international groups. The past decade has seen extraordinary increase in worldwide availability of and access to several large multiple sclerosis (MS) databases and registries. MS registries represent powerful tools to provide meaningful information on the burden, natural history, and long-term safety and effectiveness of treatments. Moreover, patients, physicians, industry, and policy makers have an active interest in real-world observational studies based on register data, as they have the potential to answer the questions that are most relevant to daily treatment decision-making. In 2014, the Italian MS Foundation, in collaboration with the Italian MS clinical centers, promoted and funded the creation of the Italian MS Register, a project in continuity with the existing Italian MS Database Network set up from 2001. Main objective of the Italian MS Register is to create an organized multicenter structure to collect data of all MS patients for better defining the disease epidemiology, improving quality of care, and promoting research projects in high-priority areas. The aim of this article is to present the current framework and network of the Italian MS register, including the methodology used to improve the quality of data collection and to facilitate the exchange of data and the collaboration among national and international groups.

Published
2019

32. MRI quality control for the Italian Neuroimaging Network Initiative: moving towards big data in multiple sclerosis

Author

Storelli, L., Rocca, M. A., Pantano, P., Pagani, E., De Stefano, N., Tedeschi, G., Zaratin, P., Filippi, M., Valsasina, P., Sibilia, M., Preziosa, P., Gallo, A., Bisecco, A., Docimo, R., Petsas, N., Ruggieri, S., Tommasin, S., Stromillo, M. L., Brocci, R. T., Storelli, L, Rocca, Ma, Pantano, P, Pagani, E, De Stefano, N, Tedeschi, G, Zaratin, P, Filippi, M, on behalf of the INNI, Network, Storelli, L., Rocca, M. A., Pantano, P., Pagani, E., De Stefano, N., Tedeschi, G., Zaratin, P., Filippi, M., Valsasina, P., Sibilia, M., Preziosa, P., Gallo, A., Bisecco, A., Docimo, R., Petsas, N., Ruggieri, S., Tommasin, S., Stromillo, M. L., and Brocci, R. T.

Subjects
Adult, Big Data, Male, Quality Control, Multiple Sclerosis, Datasets as Topic, Neuroimaging, Fluid-attenuated inversion recovery, White matter, Big data, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Magnetic resonance imaging (MRI), 030212 general & internal medicine, Neuroradiology, business.industry, Multiple sclerosis, Isocenter, Middle Aged, medicine.disease, Magnetic Resonance Imaging, Multiple sclerosis (MS), Image contrast, Italian Neuroimaging Network Initiative (INNI), Female, Italy, medicine.anatomical_structure, Neurology, Neurology (clinical), Nuclear medicine, business, 030217 neurology & neurosurgery
Abstract

The Italian Neuroimaging Network Initiative (INNI) supports the creation of a repository, where MRI, clinical, and neuropsychological data from multiple sclerosis (MS) patients and healthy controls are collected from Italian Research Centers with internationally recognized expertise in MRI applied to MS. However, multicenter MRI data integration needs standardization and quality control (QC). This study aimed to implement quantitative measures for characterizing the standardization and quality of MRI collected within INNI. MRI scans of 423 MS patients, including 3D T1- and T2-weighted, were obtained from INNI repository (from Centers A, B, C, and D). QC measures were implemented to characterize: (1) head positioning relative to the magnet isocenter; (2) intensity inhomogeneity; (3) relative image contrast between brain tissues; and (4) image artefacts. Centers A and D showed the most accurate subject positioning within the MR scanner (median z-offsets = − 2.6 ± 1.7cm and − 1.1 ± 2cm). A low, but significantly different, intensity inhomogeneity on 3D T1-weighted MRI was found between all centers (p < 0.05), except for Centers A and C that showed comparable image bias fields. Center D showed the highest relative contrast between gray and normal appearing white matter (NAWM) on 3D T1-weighed MRI (0.63 ± 0.04), while Center B showed the highest relative contrast between NAWM and MS lesions on FLAIR (0.21 ± 0.06). Image artefacts were mainly due to brain movement (60%) and ghosting (35%). The implemented QC procedure ensured systematic data quality assessment within INNI, thus making available a huge amount of high-quality MRI to better investigate pathophysiological substrates and validate novel MRI biomarkers in MS.

Published
2019

33. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

Author

Sormani, M. P., De Rossi, N., Schiavetti, I., Carmisciano, L., Cordioli, C., Moiola, L., Radaelli, M., Immovilli, P., Capobianco, M., Trojano, M., Zaratin, P., Tedeschi, G., Comi, G., Battaglia, M. A., Patti, F., Salvetti, M., the Musc-19 Study Group, Nozzolillo, A., Bellacosa, A., Protti, A., Di Sapio, A., Signori, A., Petrone, A., Bisecco, A., Iovino, A., Dutto, A., Repice, A. M., Conte, A., Bertolotto, A., Bosco, A., Gallo, A., Zito, A., Sartori, A., Giometto, B., Tortorella, C., Antozzi, C., Pozzilli, C., Mancinelli, C. R., Zanetta, C., Cordano, C., Scandellari, C., Guaschino, C., Gasperini, C., Solaro, C., Fioretti, C., Bezzini, D., Marastoni, D., Paolicelli, D., Vecchio, D., Landi, D., Bucciantini, E., Pedrazzoli, E., Signoriello, E., Sbragia, E., Susani, E. L., Curti, E., Milano, E., Marinelli, F., Camilli, F., Boneschi, F. M., Govone, F., Bovis, F., Calabria, F., Caleri, F., Rinaldi, F., Vitetta, F., Corea, F., Crescenzo, F., Teatini, F., Tabiadon, G., Granella, F., Boffa, G., Lus, G., Brichetto, G., Maniscalco, G. T., Borriello, G., De Luca, G., Konrad, G., Vaula, G., Marfia, G. A., Mallucci, G., Liberatore, G., Salemi, G., Miele, G., Sibilia, G., Pesci, I., Brambilla, L., Lopiano, L., Sinisi, L., Pasquali, L., Saraceno, L., Chiveri, L., Mancinelli, L., Grimaldi, L. M. E., Caniatti, L. M., Cava, M. D., Onofrj, M., Rovaris, M., Vercellino, M., Bragadin, M. M., Buccafusca, M., Buscarinu, M. C., Celani, M. G., Grasso, M. G., Stromillo, M. L., Petracca, M., Amato, M. P., L'Episcopo, M. R., Sessa, M., Ferrò, M. T., Ercolani, M. V., Bianco, M., M. L., Re, Vianello, M., Clerico, M., di Napoli, M., Ponzano, M., Conti, M. Z., Calabrese, M., Mirabella, M., Filippi, M., Inglese, M., Lucchini, M., Pozzato, M., Danni, M. C., Zaffaroni, M., Zampolini, M., Ponzio, M., De Riz, M., De Stefano, N., Cavalla, P., De Mitri, P., Grossi, P., Confalonieri, P., Gallo, P., Ragonese, P., Sola, P., Annovazzi, P., Iaffaldano, P., Nardone, R., Cerqua, R., Clerici, R., Lanzillo, R., Motta, R., Balgera, R., Bergamaschi, R., Totaro, R., Iodice, R., Capra, R., Marangoni, S., Realmuto, S., Cottone, S., Montepietra, S., Rasia, S., Arena, S., Bucello, S., Banfi, S., Bonavita, S., Malucchi, S., Tonietti, S., Vollaro, S., Cordera, S., Aguglia, U., Clerici, V. T., Barcella, V., Bergamaschi, V., Morra, V. B., Dattola, V., and Mantero, V.

Published
2021

34. Accurate low-dose exposure assessment of benzene and monoaromatic compounds by diffusive sampling: Sampling and analytical method validation according to ISO 23320 for radiello® samplers packed with graphitised charcoal and suitable for thermal desorption

Author

Zaratin, Laura, Boaretto, Caterina, Schianca, Riccardo Carnevale, Hinkal, George, Grignani, Elena, and Cottica, Danilo

Abstract

•Benzene exposure by inhalation at the workplace has decreased in recent years.•High quality data are needed to study health effects of benzene low dose exposure.•A diffusive method has been validated for benzene monitoring at low concentration.•Sampling and analysis method validated according to ISO 23320 standard.•Radiello® diffusive samplers with graphitized charcoal fit for benzene monitoring.

Published
2024
Full Text
View/download PDF

36. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Author

Sormani, M. P., De Rossi, N., Schiavetti, I., Carmisciano, L., Cordioli, C., Moiola, L., Radaelli, M., Immovilli, P., Capobianco, M., Trojano, M., Zaratin, P., Tedeschi, G., Comi, G., Battaglia, M. A., Patti, F., Salvetti, M., Nozzolillo, A., Bellacosa, A., Protti, A., Di Sapio, A., Signori, A., Petrone, A., Bisecco, A., Iovino, A., Dutto, A., Repice, A. M., Conte, A., Bertolotto, A., Bosco, A., Gallo, A., Zito, A., Sartori, A., Giometto, B., Tortorella, C., Antozzi, C., Pozzilli, C., Mancinelli, C. R., Zanetta, C., Cordano, C., Scandellari, C., Guaschino, C., Gasperini, C., Solaro, C., Fioretti, C., Bezzini, D., Marastoni, D., Paolicelli, D., Vecchio, D., Landi, D., Bucciantini, E., Pedrazzoli, E., Signoriello, E., Sbragia, E., Susani, E. L., Curti, E., Milano, E., Marinelli, F., Camilli, F., Boneschi, F. M., Govone, F., Bovis, F., Calabria, F., Caleri, F., Rinaldi, F., Vitetta, F., Corea, F., Crescenzo, F., Teatini, F., Tabiadon, G., Granella, F., Boffa, G., Lus, G., Brichetto, G., Maniscalco, G. T., Borriello, G., De Luca, G., Konrad, G., Vaula, G., Marfia, G. A., Mallucci, G., Liberatore, G., Salemi, G., Miele, G., Sibilia, G., Pesci, I., Brambilla, L., Lopiano, L., Sinisi, L., Pasquali, L., Saraceno, L., Chiveri, L., Mancinelli, L., Grimaldi, L. M. E., Caniatti, L. M., Cava, M. D., Onofrj, M., Rovaris, M., Vercellino, M., Bragadin, M. M., Buccafusca, M., Buscarinu, M. C., Celani, M. G., Grasso, M. G., Stromillo, M. L., Petracca, M., Amato, M. P., L'Episcopo, M. R., Sessa, M., Ferro, M. T., Ercolani, M. V., Bianco, M., Re, M. L., Vianello, M., Clerico, M., Ponzano, M., Conti, M. Z., Calabrese, M., Mirabella, Massimiliano, Filippi, M., Inglese, M., Lucchini, Matteo, Pozzato, M., Danni, M. C., Zaffaroni, M., Zampolini, M., Ponzio, M., De Riz, M., De Stefano, N., Cavalla, P., De Mitri, P., Grossi, P., Confalonieri, P., Gallo, P., Ragonese, P., Sola, P., Annovazzi, P., Iaffaldano, P., Nardone, R., Cerqua, R., Clerici, R., Lanzillo, R., Motta, R., Balgera, R., Bergamaschi, R., Totaro, R., Iodice, R., Capra, R., Marangoni, S., Realmuto, S., Cottone, S., Montepietra, S., Rasia, S., Arena, S., Bucello, S., Banfi, S., Bonavita, S., Malucchi, S., Tonietti, S., Vollaro, S., Cordera, S., Aguglia, U., Clerici, V. T., Barcella, V., Bergamaschi, V., Morra, V. B., Dattola, V., Mantero, V., di Napoli, M., Mirabella M. (ORCID:0000-0002-7783-114X), Lucchini M. (ORCID:0000-0002-0447-2297), Sormani, M. P., De Rossi, N., Schiavetti, I., Carmisciano, L., Cordioli, C., Moiola, L., Radaelli, M., Immovilli, P., Capobianco, M., Trojano, M., Zaratin, P., Tedeschi, G., Comi, G., Battaglia, M. A., Patti, F., Salvetti, M., Nozzolillo, A., Bellacosa, A., Protti, A., Di Sapio, A., Signori, A., Petrone, A., Bisecco, A., Iovino, A., Dutto, A., Repice, A. M., Conte, A., Bertolotto, A., Bosco, A., Gallo, A., Zito, A., Sartori, A., Giometto, B., Tortorella, C., Antozzi, C., Pozzilli, C., Mancinelli, C. R., Zanetta, C., Cordano, C., Scandellari, C., Guaschino, C., Gasperini, C., Solaro, C., Fioretti, C., Bezzini, D., Marastoni, D., Paolicelli, D., Vecchio, D., Landi, D., Bucciantini, E., Pedrazzoli, E., Signoriello, E., Sbragia, E., Susani, E. L., Curti, E., Milano, E., Marinelli, F., Camilli, F., Boneschi, F. M., Govone, F., Bovis, F., Calabria, F., Caleri, F., Rinaldi, F., Vitetta, F., Corea, F., Crescenzo, F., Teatini, F., Tabiadon, G., Granella, F., Boffa, G., Lus, G., Brichetto, G., Maniscalco, G. T., Borriello, G., De Luca, G., Konrad, G., Vaula, G., Marfia, G. A., Mallucci, G., Liberatore, G., Salemi, G., Miele, G., Sibilia, G., Pesci, I., Brambilla, L., Lopiano, L., Sinisi, L., Pasquali, L., Saraceno, L., Chiveri, L., Mancinelli, L., Grimaldi, L. M. E., Caniatti, L. M., Cava, M. D., Onofrj, M., Rovaris, M., Vercellino, M., Bragadin, M. M., Buccafusca, M., Buscarinu, M. C., Celani, M. G., Grasso, M. G., Stromillo, M. L., Petracca, M., Amato, M. P., L'Episcopo, M. R., Sessa, M., Ferro, M. T., Ercolani, M. V., Bianco, M., Re, M. L., Vianello, M., Clerico, M., Ponzano, M., Conti, M. Z., Calabrese, M., Mirabella, Massimiliano, Filippi, M., Inglese, M., Lucchini, Matteo, Pozzato, M., Danni, M. C., Zaffaroni, M., Zampolini, M., Ponzio, M., De Riz, M., De Stefano, N., Cavalla, P., De Mitri, P., Grossi, P., Confalonieri, P., Gallo, P., Ragonese, P., Sola, P., Annovazzi, P., Iaffaldano, P., Nardone, R., Cerqua, R., Clerici, R., Lanzillo, R., Motta, R., Balgera, R., Bergamaschi, R., Totaro, R., Iodice, R., Capra, R., Marangoni, S., Realmuto, S., Cottone, S., Montepietra, S., Rasia, S., Arena, S., Bucello, S., Banfi, S., Bonavita, S., Malucchi, S., Tonietti, S., Vollaro, S., Cordera, S., Aguglia, U., Clerici, V. T., Barcella, V., Bergamaschi, V., Morra, V. B., Dattola, V., Mantero, V., di Napoli, M., Mirabella M. (ORCID:0000-0002-7783-114X), and Lucchini M. (ORCID:0000-0002-0447-2297)

Abstract

Objective: This study was undertaken to assess the impact of immunosuppressive and immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID-19) in people with multiple sclerosis (PwMS). Methods: We retrospectively collected data of PwMS with suspected or confirmed COVID-19. All the patients had complete follow-up to death or recovery. Severe COVID-19 was defined by a 3-level variable: mild disease not requiring hospitalization versus pneumonia or hospitalization versus intensive care unit (ICU) admission or death. We evaluated baseline characteristics and MS therapies associated with severe COVID-19 by multivariate and propensity score (PS)-weighted ordinal logistic models. Sensitivity analyses were run to confirm the results. Results: Of 844 PwMS with suspected (n = 565) or confirmed (n = 279) COVID-19, 13 (1.54%) died; 11 of them were in a progressive MS phase, and 8 were without any therapy. Thirty-eight (4.5%) were admitted to an ICU; 99 (11.7%) had radiologically documented pneumonia; 96 (11.4%) were hospitalized. After adjusting for region, age, sex, progressive MS course, Expanded Disability Status Scale, disease duration, body mass index, comorbidities, and recent methylprednisolone use, therapy with an anti-CD20 agent (ocrelizumab or rituximab) was significantly associated (odds ratio [OR] = 2.37, 95% confidence interval [CI] = 1.18–4.74, p = 0.015) with increased risk of severe COVID-19. Recent use (<1 month) of methylprednisolone was also associated with a worse outcome (OR = 5.24, 95% CI = 2.20–12.53, p = 0.001). Results were confirmed by the PS-weighted analysis and by all the sensitivity analyses. Interpretation: This study showed an acceptable level of safety of therapies with a broad array of mechanisms of action. However, some specific elements of risk emerged. These will need to be considered while the COVID-19 pandemic persists. ANN NEUROL 2021;89:780–789.

Published
2021

42. Abstracts of the 6th FECS Conference 1998 Lectures

Author

Rowland, F. Sherwood, Blake, Donald R., Larsen, B. R., Lindskog, Anne, Peterson, Peter J., Williams, W. Peter, Wallington, T. J., Pilling, M. J., Carslaw, N., Creasey, D. J., Heard, D. E., Jacobs, P., Lee, J., Lewis, A. C., McQuaid, J. B., Stockwell, William R., Frank, Hartmut, Sacco, P., Cocheo, V., Lynge, E., Andersen, A., Nilsson, R., Barlow, L., Pukkala, E., Nordlinder, R., Boffetta, P., Grandjean, P., Heikkil, P., Hürte, L. G., Jakobsson, R., Lundberg, I., Moen, B., Partanen, T., Riise, T., Borowiak, A., De Saeger, E., Schnitzler, K. G., Gravenhorst, G., Jacobi, H. W., Moelders, S., Lammel, G., Busch, G., Beese, F. O., Dentener, F. J., Feichter, J., Fraedrich, K., Roelofs, G. J., Friedrich, R., Reis, S., Voehringer, F., Simpson, D., Moussiopoulos, N., Sahm, P., Tourlou, P. M., Salmons, R., Papameletiou, D., Maqueda, J. M., Suhr, Per B., Bell, W., Paton-Walsh, C., Woods, P. T., Partridge, R. H., Slemr, J., Slemr, F., Schmidbauer, N., Ravishankara, A. R., Jenkin, Michael E., de Leeuw, G., van Eijk, A. M. J., Flossmann, A. I., Wobrock, W., Mestayer, P. G., Tranchant, B., Ljungström, E., Karlsson, R., Larsen, S. E., Roemer, M., Builtjes, P. J. H., Koffi, Brigitte, Koffi, Ernest N’Dri, De Saeger, Emile, Ro-Poulsen, H., Mikkelsen, T. N., Hummelshøj, P., Hovmand, M. F., Simoneit, Bernd R. T., van der Meulen, A., Meyer, Michael B., Berndt, T., Böge, O., Stratmann, F., Cass, Glen R., Harrison, Roy M., Shi, Ji Ping, Hoffmann, T., Warscheid, B., Bandur, R., Marggraf, U., Nigge, W., Kamens, Richard, Jang, Myoseon, Strommen, Mike, Chien, Chao-Jung, Leach, Keri, Ammann, M., Kalberer, M., Arens, F., Lavanchy, V., Gâggeler, H. W., Baltensperger, U., Davies, J. A., Cox, R. A., Alonso, S. García, Pastor, R. Pérez, Argüello, Gustavo A., Willner, Helge, Berndt, T., Böge, O., Bogillo, V. I., Pokrovskiy, V. A., Kuraev, O. V., Gozhyk, P. F., Bolzacchini, E., Bruschi, M., Fantucci, P., Meinardi, S., Orlandi, M., Rindone, B., Bolzacchini, Ezio, Bohn, Birger, Rindone, Bruno, Bruschi, Maurizo, Zetzsch, Cornelius, Brussol, C., Duane, M., Larsen, B., Carlier, P., Kotzias, D., Caracena, A. Baeza, Aznar, A. Miñana, Ferradás, E. González, Christensen, C. S., Skov, H., Hummelshøj, P., Jensen, N. O., Lohse, C., Cocheo, V., Sacco, P., Chatzis, C., Cocheo, V., Sacco, P., Boaretto, C., Quaglio, F., Zaratin, L., Pagani, D., Cocheo, L., Cocheo, Vincenzo, Asnar, Agustin Minana, Baldan, Annerita, Ballesta, Pascual P., Boaretto, Caterina, Caracena, Antonia B., Ferradas, Enrique Gonzalez, Gonzalez-Flesca, Nobert, Goelen, Eddie, Hansen, Asger B., Sacco, Paolo, De Saeger, Emile, Skov, Henrik, Consonni, V., Gramatica, P., Santagostino, A., Galvani, P., Bolzacchini, E., Consonni, Viviana, Gramatica, Paola, Todeschini, Roberto, Dippel, G., Reinhardt, H., Zellner, R., Dämmer, K., Bednarek, G., Breil, M., Zellner, R., Febo, A., Allegrini, I., Giliberti, C., Perrino, C., Fogg, P. G. T., Geiger, H., Barnes, I., Becker, K. H., Maurer, T., Geyskens, F., Bormans, R., Lambrechts, M., Goelen, E., Giese, Martina, Frank, Hartmut, Glasius, M., Hornung, P., Jacobsen, J. K., Klausen, H. S., Klitgaard, K. C., Møller, C. K., Petersen, A. P. F., Petersen, L. S., Wessel, S., Hansen, T. S., Lohse, C., Boaretto, E., Heinemeier, J., Glasius, M., Di Bella, D., Lahaniati, M., Calogirou, A., Jensen, N. R., Hjorth, J., Kotzias, D., Larsen, B. R., Gonzalez-Flesca, N., Cicolella, A., Bates, M., Bastin, E., Gurbanov, M. A., Akhmedly, K. M., Balayev, V. S., Haselmann, K. F., Ketola, R., Laturnus, F., Lauritsen, F. R., Grøn, C., Herrmann, H., Ervens, B., Reese, A., Umschlag, Th., Wicktor, F., Zellner, R., Herrmann, H., Umschlag, Th., Müller, K., Bolzacchini, E., Meinardi, S., Rindone, B., Jenkin, Michael E., Hayman, Garry D., Jensen, N. O., Courtney, M., Hummelshøj, P., Christensen, C. S., Larsen, B. R., Johnson, Matthew S., Hegelund, Flemming, Nelander, Bengt, Kirchner, Frank, Klotz, B., Barnes, Ian, Sørensen, S., Becker, K. H., Etzkorn, T., Platt, U., Wirtz, K., Martín-Reviejo, M., Laturnus, Frank, Martinez, E., Cabañas, B., Aranda, A., Martín, P., Salgado, S., Rodriguez, D., Masclet, P., Jaffrezo, J. L., Hillamo, R., Mellouki, A., Le Calvé, S., Le Bras, G., Moriarty, J., O’Donnell, S., Wenger, J., Sidebottom, H., Mingarrol, M. T. Bomboi, Cosin, S., Pastor, R. Pérez, Alonso, S. García, Sanz, M. J., Bravo, I., Gonzalez, D., Pérez, M. A., Mustafaev, Islam, Mammadova, Saida, Noda, J., Hallquist, M., Langer, S., Ljungström, E., Nohara, K., Kutsuna, S., Ibusuki, T., Oehme, Michael, Kölliker, Stephan, Brombacher, Stephan, Merz, Leo, Pastor, R. Pérez, Alonso, S. García, Cabezas, A. Quejido, Peeters, J., Vereecken, L., El Yazal, J., Pfeffer, Hans-Ulrich, Breuer, Ludger, Platz, J., Nielsen, O. J., Sehested, J., Wallington, T. J., Ball, J. C., Hurley, M. D., Straccia, A. M., Schneider, W. F., Pérez-Casany, M. P., Nebot-Gil, I., Sánchez-Marín, J., Putz, E., Folberth, G., Pfister, G., Weissflog, L., Elansky, N. P., Sørensen, Søren, Barnes, Ian, Becker, K. H., Shao, M., Heiden, A. C., Kley, D., Rockel, P., Wildt, J., Silva, G. V. A., Vasconcelos, M. T., Fernandes, E. O., Santos, A. M. S., Skov, Henrik, Hansen, Asger, Løfstrøm, Per, Lorenzen, Gitte, Stabel, J. R., Wolkoff, P., Pedersen, T., Strom, A. B., Skov, Henrik, Hertel, Ole, Jensen, Finn Palmgren, Hjorth, Jens, Galle, Bosse, Wallin, Svante, Theloke, J., Libuda, H. G., Zabel, F., Touaty, Muriel, Bonsang, Bernard, Ullerstam, M., Langer, S., Ljungström, E., Wenger, John, Bonard, Amélie, Manning, Marcus, Nolan, Sinéad, O’Sullivan, Niamh, Sidebottom, Howard, Wenger, John, Collins, Eoin, Moriarty, Jennie, O’Donnell, Sinéad, Sidebottom, Howard, Wenger, John, Collins, Eoin, Moriarty, Jennie, O’Donnell, Sinéad, Sidebottom, Howard, Wenger, John, Sidebottom, Howard, Chadwick, Paul, O’Leary, Barbara, Treacy, Jack, Wolkoff, Peder, Clausen, Per A., Wilkins, Cornelius K., Hougaard, Karin S., Nielsen, Gunnar D., Zilinskis, Viktors, Jansons, Guntis, Peksens, Aigars, Lazdins, Agris, Arinci, Y. V., Erdöl, N., Ekinci, E., Okutan, H., Manlafalioglu, I., Bakeas, Evangelos B., Siskos, Panayotis A., Viras, Loizos G., Smirnioudi, Vasiliki N., Bottenheim, Jan W., Biesenthal, Thomas, Gong, Wanmin, Makar, Paul, Delmas, Véronique, Menard, Tamara, Tatry, Véronique, Moussafir, Jacques, Thomas, Dominique, Coppalle, Alexis, Ellermann, Thomas, Hertel, Ole, Skov, Henrik, Frohn, Lise, Manscher, Ole H., Friis, Jørgen, Girgzdiene, Rasa, Girgzdys, Aloyzas, Gurevich, N. A., Gårdfeldt, Katarina, Langer, Sarka, Hermans, C., Vandaele, A. C., Carleer, M., Fally, S., Colin, R., Bernath, P. F., Jenouvrier, A., Coquart, B., Mérienne, M. -F., Hertel, Ole, Frohn, Lise, Skov, Henrik, Ellermann, Thomas, Huntrieser, H., Schlager, H., Feigl, C., Kemp, Kåre, Palmgren, Finn, Kiilsholm, Sissi, Rasmussen, Alix, Sørensen, Jens Havskov, Klemm, Otto, Lange, Holger, Larsen, René Wugt, Larsen, Niels Wessel, Nicolaisen, Flemming, Sørensen, Georg Ole, Beukes, Jon Are, Larsen, Poul Bo, Jensen, Steen Solvang, Fenger, Jes, de Leeuw, Gerrit, Kunz, Gerard, Cohen, Leo, Schlünzen, Heinke, Muller, Frank, Schulz, Michael, Tamm, Susanne, Geernaert, Gary, Hertel, Ole, Pedersen, Britta, Geernaert, Lise Lotte Sørensen, Lund, Søren, Vignati, Elisabetta, Jickells, Tim, Spokes, Lucinda, Matei, C., Jinga, O. A., Jinga, D. C., Moliner, R., Braekman-Danheux, C., Fontana, A., Suelves, I., Thieman, T., Vassilev, S., Skov, Henrik, Hertel, Ole, Zlatev, Zahari, Brandt, Jørgen, Bastrup-Birk, Annemarie, Ellermann, Thomas, Frohn, Lise, Vandaele, A. C., Hermans, C., Carleer, M., Tsouli, A., Colin, R., Windsperger, Andreas M., Turi, Kristina, Dworak, Oliver, Zellweger, C., Weingartner, E., Rüttimann, R., Hofer, P., Baltensperger, U., Ziv, A., Iakovleva, E., Palmgren, F., Berkovicz, R., Skov, H., Alastuey, A., Querol, X., Chaves, A., Lopez-Soler, A., Ruiz, C., Andrees, J. M., Allegrini, I., Febo, A., Giusto, M., Angeloni, M., Di Filippo, P., D’Innocenzio, F., Lepore, L., Marconi, A., Arshinov, M. Yu., Belan, B. D., Davydov, D. K., Kovaleskii, V. K., Plotinov, A. P., Pokrovskii, E. V., Sklyadneva, T. K., Tolmachev, G. N., Arshinov, M. Yu., Belan, B. D., Sklyadneva, T. K., Behnke, Wolfgang, Elend, Manfred, Krüger, Ulrich, Zetzsch, Cornelius, Belan, B. D., Arshinov, M. Yu., Davydov, D. K., Kovalevskii, V. K., Plotnikov, A. P., Pokrovskii, E. V., Rasskazchikova, T. M., Sklyadneva, T. K., Tolmachev, G. N., Belan, B. D., Arshinov, M. Yu., Simonenkov, D. V., Tolmachev, G. N., Bilde, Merete, Aker, Pamela M., Börensen, C., Kirchner, U., Scheer, V., Vogt, R., Ellermann, T., Geernaert, L. L. S., Pryor, S. C., Barthelmie, R. J., Feilberg, Anders, Nielsen, Torben, Kamens, Richard M., Freitas, M. C., Marques, A. P., Reis, M. A., Alves, L. C., Ilyinskikh, N. N., Ilyinskikh, I. N., Ilyinskikh, E. N., Johansen, Keld, Stavnsbjerg, Peter, Gabrielsson, Pär, Bak, Flemming, Andersen, Erik, Autrup, Herman, Kamens, Richard, Jang, Myoseon, Strommen, Michael, Leach, Keri, Kirchner, U., Scheer, V., Börensen, C., Vogt, R., Igor, Komov, Svjatoslav, Galiy, Anatoliy, Burlak, Komov, I. L., Istchenko, A. A., Lourenço, M. G., MacTavish, D., Sirois, A., Masclet, Pierre, Jaffrezo, Jean Luc, van der Meulen, A., Milukaite, A., Morkunas, V., Jurgutis, P., Mikelinskiene, A., Nielsen, Torben, Feilberg, Anders, Binderup, Mona Lise, Pineda, M., Palacios, J. M., Garcia, E., Cilleruelo, C., Moliner, R., Popovitcheva, O. B., Trukhin, M. E., Persiantseva, N. M., Buriko, Yu, Starik, A. M., Demirdjian, B., Suzanne, J., Probst, T. U., Rietz, B., Alfassi, Z. B., Pokrovskiy, V. A., Zenobi, R., Bogatyr’ov, V. M., Gun’ko, V. M., Querol, X., Alastuey, A., Lopez-Soler, A., Mantilla, E., Plana, F., Artiño, B., Rauterberg-Wulff, A., Israël, G. W., Rocha, Teresa A. P., Duarte, Armando C., Röhrl, Andreas, Lammel, Gerhard, Spindler, G., Müller, K., Herrmann, H., Strommen, Michael R., Vignati, Elisabetta, de Leeuw, Gerrit, and Berkowicz, Ruwim

Published
1998
Full Text
View/download PDF

43. SARS software for analysis of radiographic images of Urochloa decumbens (Stapf) RD Webster seeds.

Author

Fernandes Ramos, Amanda Karoliny, Dantas de Medeiros, André, Dias Pereira, Márcio, Felipe Araújo, Yuri, Junio da Silva, Laércio, and Zaratin Alves, Charline

Abstract

Copyright of Journal of Seed Science is the property of Associacao Brasileira de Tecnologia de Sementes and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2022
Full Text
View/download PDF

44. Atmospheric plasma overcomes dormancy of Pityrocarpa moniliformis (Benth.) Luckow & R. W. Jobson seeds.

Author

Balduino Nicolau, Josefa Patricia, Dias Pereira, Márcio, Eudes da Silva, Francisco, da Silva Souza, Dinnara Layza, Dantas de Medeiros, André, and Zaratin Alves, Charline

Abstract

Copyright of Journal of Seed Science is the property of Associacao Brasileira de Tecnologia de Sementes and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2022
Full Text
View/download PDF

45. Non-surgical interventions for the treatment of masticatory muscular spasticity in patients with cerebral palsy. Systematic review of randomized clinical trials.

Author

Rocha, Monise Mendes, Martimbianco, Ana Luiza Cabrera, Beltramin, Rafael Zaratin, Horliana, Anna Carolina Ratto Tempestini, Santos, Elaine Marcílio, Mesquita-Ferrari, Raquel Agnelli, Fernandes, Kristianne Porta Santos, Motta, Lara Jansiski, Turcio, Karina Helga, Gonçalves, Marcela Leticia Leal, and Bussadori, Sandra Kalil

Abstract

Muscle disorders caused by cerebral palsy (CP) can affect oral function. The treatment for masticatory muscle spasticity is important to minimize muscle hyperactivity and preclude oral damages. Objectives: To evaluate the efficacy and safety of non-surgical interventions for the treatment of masticatory muscle spasticity in CP patients. Methods: A comprehensive search was performed in the following databases: MEDLINE, Embase, Cochrane Library, LILACS, BBO, PEDro, Clinicaltrials.gov and WHO/ICTRP, without date and language restrictions. Randomized controlled trials (RCT) evaluating non-surgical interventions were considered. Primary outcomes such as masticatory function and adverse events were planned to be assessed. The risk of bias assessment was performed using the Cochrane risk of bias tool. The certainty of the evidence was assessed using the GRADE approach. Results: Three RCT assessing the effects of botulinum toxin, functional masticatory training and neuromuscular electrostimulation (NMES) were included. Evidence with a very low certainty showed: (i) no difference between botulinum toxin and placebo regarding maximum chewing strength, chewing efficiency and global oral health scale; (ii) improvement in masticatory function in favor of functional masticatory training versus conventional exercises, and (iii) in favor of strengthening exercises plus NMES versus placebo. Conclusions: There was insufficient evidence to support the use of botulinum toxin and masticatory muscle strengthening programs alone and associated with NMES for the treatment of masticatory muscle in patients with PC. The clinical decision must be individualized, and further studies are needed to support or refute the use of different non-surgical interventions for PC. PROSPERO register number CRD42020209761. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

47. Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: a qualitative study nested in a randomized controlled trial

Author

Borreani, C., Giovannetti, A. M., Bianchi, E., Giordano, A., Cilia, S., Cipollari, S., Rossi, I., Cavallaro, C., Clerici, V. Torri, Rossetti, E., Stefanelli, M. C., Totis, A., Pappalardo, A., Occhipinti, G., Confalonieri Paolo, Veronese, S., Grasso, M. G., Patti, F., Zaratin, P., Battaglia, M. A., and Solari, A.

Published
2018

48. Participant perspectives of a home-based palliative approach for people with severe multiple sclerosis: A qualitative study

Author

Giovannetti, A. M., Borreani, C., Bianchi, E., Giordano, A., Cilia, S., Cipollari, S., Rossi, I., Cavallaro, C., Clerici, V. T., Rossetti, E., Stefanelli, M. C., Totis, A., Pappalardo, A., Occhipinti, G., Confalonieri, P., Veronese, S., Grasso, M. G., Patti, F., Zaratin, P., Battaglia, M. A., Solari, A., Amadeo, R., Ponzio, M., Lugaresi, A., Martino, G., Palmisano, L., Pagano, E., Radice, D., Farinotti, M., Ferrari, G., Rosato, R., Oliver, D. J., Pucci, E., Tesio, L., Pietrolongo, E., Giuntoli, M., Fittipaldo, A., Cugno, C., Causarano, R., Morino, P., Campanella, A., Mantegazza, R., Tucci, L., Ippoliti, F., Morone, G., Fusco, A., Cascio, V., Cimino, V., Zagari, F., Lopes de Carvalho, M. L., Motta, R., Onofrj, M., Da Col, D., and Casale, G.

Subjects
Male, Genetics and Molecular Biology (all), Palliative care, Medical Doctors, Psychologists, Team Role Inventories, Health Care Providers, medicine.medical_treatment, Nurses, Social Sciences, lcsh:Medicine, Referring Physician, Severity of Illness Index, Biochemistry, law.invention, 0302 clinical medicine, Sociology, Randomized controlled trial, Biochemistry, Genetics and Molecular Biology (all), Agricultural and Biological Sciences (all), law, Medicine and Health Sciences, Medical Personnel, 030212 general & internal medicine, Human Families, lcsh:Science, Aged, 80 and over, Multidisciplinary, Rehabilitation, Palliative Care, Neurodegenerative Diseases, Qualitative Studies, Middle Aged, Home Care Services, Professions, Neurology, Research Design, Female, Psychology, Research Article, Adult, Multiple Sclerosis, Drug Research and Development, Patients, Immunology, Research and Analysis Methods, Autoimmune Diseases, 03 medical and health sciences, Nursing, Physicians, Intervention (counseling), medicine, Humans, Clinical Trials, Aged, Pharmacology, lcsh:R, Biology and Life Sciences, Demyelinating Disorders, Focus group, Randomized Controlled Trials, Health Care, People and Places, Population Groupings, Clinical Immunology, lcsh:Q, Clinical Medicine, 030217 neurology & neurosurgery, Qualitative research
Abstract

Background We performed a qualitative study to investigate the experiences of participants in a multicentre randomized controlled trial on a home-based palliative approach (HPA) for adults with severe multiple sclerosis (MS) and their caregivers. Our aim was to explore the strengths and challenges of the intervention, and circumstances that may have influenced its efficacy. Methods Participants to the qualitative study were the patients, their caregivers, patient referring physicians, and the teams who delivered the HPA intervention. We performed semi-structured one-on-one interviews with 12 patients and 15 informal caregivers chosen using a maximum variation strategy, two focus group meetings with patient referring physicians (4 participants each), and one with the HPA teams (9 participants). Results From data analysis (framework method) 38 sub-categories emerged, which were grouped into 10 categories and 3 themes: 'expectations,' 'met and unmet needs', and 'barriers’. Intervention benefits were improved control of symptoms and reduced sense of isolation of the patient-caregiver dyads. Limitations were: factors related to experimental design (difficulty of dyads in identifying examiner and team roles, additional burden for caregivers); team issues (insufficient team building /supervision, competing priorities); limitations of the intervention itself (insufficient length, lack of rehabilitation input); and external factors (resource limitations, under-responsive services/professionals). The referring physician focus groups provided little experiential data. Conclusions The HPA reduced patient symptoms and sense of isolation in patients and caregivers. The indirect role of the HPA teams, and insufficient length of the intervention were key limitations. The experimental design imposed additional burdens on the dyads. Key barriers were the paucity of available services, the demanding administrative procedures, and lack of networking facilities. These findings suggest that two major requirements are necessary for home palliative care to be effective in this patient population: HPA teams well-connected with MS rehabilitation services, and care delivered over the long-term, with variable intensity. Trial registration Current Controlled Trials ISRCTN73082124 (Registered 19/06/2014).

Published
2018

49. Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis

Author

Solari, A., Giordano, A., Patti, F., Grasso, M. G., Confalonieri, P., Palmisano, L., Ponzio, M., Borreani, C., Rosato, R., Veronese, S., Zaratin, P., Battaglia, M. A., Amadeo, R., Lugaresi, A., Martino, G., Pagano, E., Radice, D., Farinotti, M., Ferrari, G., Oliver, D. J., Pucci, E., Tesio, L., Pietrolongo, E., Giuntoli, M., Fittipaldo, A., Cugno, C., Causarano, R., Morino, P., Campanella, A., Mantegazza, R., Tucci, L., Ippoliti, F., Morone, G., Fusco, A., Cascio, V., Cimino, V., Zagari, F., Lopes de Carvalho, M. L., Motta, R., Onofrj, M., Da Col, D., and Casale, G.

Subjects
Male, medicine.medical_specialty, caregivers, symptom burden, Palliative care, Aftercare, Severity of Illness Index, law.invention, Multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), Randomized controlled trial, law, Activities of Daily Living, medicine, Humans, 030212 general & internal medicine, palliative care, quality of life, randomized controlled trial, Aged, business.industry, Symptom burden, Middle Aged, medicine.disease, Home based, Home Care Services, Treatment Outcome, Neurology, Italy, Multivariate Analysis, Physical therapy, Disease Progression, Female, Neurology (clinical), Homebound Persons, business, Original Research Papers, 030217 neurology & neurosurgery
Abstract

Background: Evidence on the efficacy of palliative care in persons with severe multiple sclerosis (MS) is scarce. Objective: To assess the efficacy of a home-based palliative approach (HPA) for adults with severe MS and their carers. Methods: Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC). At each center, a multi-professional team delivered the 6-month intervention. A blind examiner assessed dyads at baseline, 3 months, and 6 months. Primary outcome measures were Palliative care Outcome Scale-Symptoms-MS (POS-S-MS) and Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW, not assessed in severely cognitively compromised patients). Results: Of 78 dyads randomized, 76 (50 HPA, 26 UC) were analyzed. Symptom burden (POS-S-MS) significantly reduced in HPA group compared to UC ( p = 0.047). Effect size was 0.20 at 3 months and 0.32 at 6 months, and statistical significance was borderline in per-protocol analysis ( p = 0.062). Changes in SEIQoL-DW index did not differ in the two groups, as changes in secondary patient and carer outcomes. Conclusion: HPA slightly reduced symptoms burden. We found no evidence of HPA efficacy on patient quality of life and on secondary outcomes.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results